• Bouffard, D.Y. & Momparler, R.L. (1995) Comparison of the induction of apoptosis in human leukemia cell lines by 2′, 2′-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside. Leukemia Research, 19, 849856.DOI: 10.1016/0145-2126(95)00067-4
  • Coiffier, B., Berger, F., Bryon, P.A. & Magaud, J.P. (1988) T-cell lymphomas: immunologic, histologic, clinical and therapeutic analysis of 63 cases. Journal of Clinical Oncology, 6, 15841589.
  • Ho, A.D., Suciu, S., Strychmans, P., De Cataldo, F., Willemze, R., Thaler, J., Peetermans, M., Dohner, H., Solbu, G., Dardenne, M. & Zittoun, R. (1999) Pentostatin in T-cell malignancies: a phase II trial of the EORTC leukemia cooperative group. Annals of Oncology, 10, 14931498.
  • Horning, S.J., Weiss, L.M., Crabtree, G.S. & Wambe, R.A. (1986) Clinical and phenotypic diversity of T-cell lymphomas. Blood, 67, 15781582.
  • Jaffe, E.S. (1984) Pathologic and clinical spectrum of post-thymic T-cell malignancy. Cancer Investigation, 2, 413419.
  • Lorand-Metze, I., Oliveira, A.B. & Aranha, F.J. (1998) Treatment of prolymphocytic leukemia with cladribine. Annals of Hematology, 76, 8586.DOI: 10.1007/s002770050368
  • Moore, M. (1996) Activity of gemcitabine in patients with advanced pancreatic carcinoma, a review. British Journal of Cancer, 78, 1519.
  • Pawson, R., Dyer, M.T., Barge, R., Matutes, E., Thornton, P.D., Emmett, E., Kluin-Nelemans, J.C., Fibbe, W.E., Willemze, R. & Catovsky, R. (1997) Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. Journal of Clinical Oncology, 15, 26672672.
  • Pinkus, G.S., O'Hara, C.J. & Said, J.W. (1990) Peripheral/post-thymic T-cell lymphomas: a spectrum of disease: clinical, pathologic and immunologic features of 78 cases. Cancer, 65, 971978.
  • Sallah, S., Wehbie, R., Lepera, P., Sallah, W. & Bobzien, W. (1999) The role of 2-chlorodeoxyadenosive in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinaemia. British Journal of Haematology, 104, 163165.
  • Santoro, A., Bredenfeld, H., Devizzi, L., Tesch, H., Bonfante, V., Viviani, S., Fiedler, F., Parra, H.S., Bendehr, C., Pacini, M., Bonadonna, A. & Diehl, V. (2000) Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study. Journal of Clinical Oncology, 18, 26152619.
  • Zinzani, P.L., Baliva, G., Magagnoli, M., Bendandi, M., Modugno, G., Gherlinzoni, F., Orcioni, G.F., Arcani, S., Simoni, R., Pileri, S.A. & Tura, S. (2000) Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients. Journal of Clinical Oncology, 18, 26032606.